Lack of p53 protein immunoreactivity in bilateral diffuse uveal melanocytic proliferation

Retina

Volumn 17, Issue 5, 1997, Pages 434-436

  Margo, Curtis E ^a,c   Lowery, Ronald L ^a   Kerschmann, Russell L ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; MELANOCYTE; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION; TUMOR SUPPRESSOR GENE; UVEA TUMOR;

EID: 0031414728     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199717050-00012     Document Type: Article

References (23)

1. Ryll DL, Campbell RJ, Robertson DM, Brubaker SJ. Pseudometastatic lesions of the choroid. Ophthalmology 1980;87:1181-1186.
2. Barr CC, Zimmerman LE, Curtic VT, Font RL. Bilateral diffuse melanocytic uveal tumors associated with systemic malignancy: a recently recognized syndrome. Arch Ophthalmol 1982;100:249-255.
3. Prause JU, Jensen OA, Eisgart F, et al. Bilateral diffuse malignant melanoma of the uvea associated with large cell carcinoma, giant cell type, of the lung. Ophthalmolgica (Basel) 1984;189:221-228.
4. Mullaney J, Mooney D, O'Oconnor M, McDonald GSA. Bilateral ovarian carcinoma with bilateral uveal melanoma. Br J Ophthalmol 1984;68:261-267.
5. Filipic M. Bilateral diffuse melanocytic uveal tumours associated with systemic malignant neoplasm. Aust N Z J Ophthalmol 1986;14:293-299.
6. Tsukahara S, Wakui K, Ohzeki S. Simultaneous bilateral primary diffuse malignant uveal melanoma: case report with pathological examination. Br J Ophthalmol 1986;70:33-38.
7. Margo CE, Pavan PR, Gendelman D, Gragoudas E. Bilateral melanocytic tumors associated with systemic malignancy: malignant melanomas or benign paraneoplastic syndrome. Retina 1987;7:137-141.
8. Gass JDM, Gieser RG, Wilkinson CP, et al. Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol 1990;108:527-533.
9. Kerschmann RL, McCalmont TH, LeBoit PE. P53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 1994; 130:181-186.
10. Shi SR, Key ME, Kalra AL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:471-478.
11. Weinberg RA. Tumor suppressor genes. Science 1992; 254;1139-1146.
12. Hollingsworth RE, Lee WH. Tumour suppressor genes: new prospects for cancer research. J Natl Cancer Inst 1991; 83:91-96.
13. Harris AL. Mutant p53: the commonest genetic abnormality in human cancer? J Pathol 1990;162:5-6.
14. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-679.
15. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors: an immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 1992;140:145-153.
16. Stretch JF, Gatter KC, Ralfkiiaer E, et al. Expression of mutant p53 in melanoma. Cancer Res 1991;51:5976-5979.
17. Tobal K, Warren W, Cooper CS, et al. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-904.
18. Jay M, McCartney ACE. Familial malignant melanoma of the uvea and p53: a victorian detective story. Surv Ophthalmol 1993;37:457-462.
19. Jay V, Yi Q, Hunter WS, Zielenska. P53 expression in uveal malignant melanomas. Pathology 1996;28:306-308.
20. JansBen K, Kuntze J, Busse H, Schmid KW. P53 oncoprotein overexpression in choroidal melanoma. Mod Pathol 1996;9:267-272.
21. Kishore K, Ghazvini S, Char DH, Kroll S, Selle J. P53 gene and cell cycling in uveal melanoma. Am J Ophthalmol 1996;121:561-567.
22. Banks L, Matlashewski G, Crawford L. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986;159:529-534.
23. McNutt NS, Saenz-Santamaria G, Volkenandt M, et al. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994;130:225-232.